Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Dec 8, 2015
Filed with the SEC on Dec 8, 2015 and accepted by EDGAR at Dec 8, 2015, 21:14 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 2.03 New direct financial obligation
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000875320-15-000058. Last ingested by Listed: Nov 11, 2026, 01:11 ET. Listed shows no prices and gives no investment advice.